LGBT Cancer Survivors and Disparities-Related Barriers That May Affect Survival

Addressing Lung Cancer Screening Disparities in the LGBT Community

Study Identifies Lung Cancer Areas of Improvement Across Asia-Pacific Region

Examining Value and Access in Lung Cancer Care, From Screening to Treatment

Benefit to Pembrolizumab Observed in Previously Treated Malignant Pleural Mesothelioma Irrespective of PD-L1 Status

Treatment of Immunotherapy-Related Ophthalmic Toxicities: An Interview With Dr. Asim V. Farooq

Understanding and Targeting SCLC

KRAS: Old Target, New Hope

Molecular Resistance Mechanisms to EGFR, ALK, and ROS1 TKIs

Approval of Combination Ipilimumab and Nivolumab for Mesothelioma: What Happens Now?

Mutation or Amplification: Who MET the Expectations?

RET Therapy for NSCLC, a New Generation of Inhibitors